NCT02282020 · Interventional trial
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
Overall registry status Completed
Phase 3
Conditions Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Delaware Valley sites
- Research Site · Abington, PA · Montgomery County
First posted
Registry updated
Added to the directory